Initial Public Offering
Search documents
Elite Express Holding Inc. Announces Pricing of $15.2 Million Initial Public Offering
Globenewswire· 2025-08-20 23:53
Company Overview - Elite Express Holding Inc. (ETS) is a Delaware holding company that operates through its wholly owned subsidiary, JAR Transportation Inc., based in California [5] - ETS specializes in last-mile delivery services, focusing on transporting packages from distribution centers to end customers within defined service areas [5] - The company utilizes logistics software to enhance operational efficiency, route planning, driver oversight, and regulatory compliance [5] Initial Public Offering (IPO) Details - ETS announced the pricing of its initial public offering of 3,800,000 shares of Class A common stock at a public offering price of $4.00 per share, resulting in gross proceeds of approximately $15.2 million before deducting underwriting discounts and offering expenses [1] - The underwriters have a 45-day option to purchase up to an additional 570,000 shares of Class A common stock at the initial public offering price [1] - The shares are expected to begin trading on the Nasdaq Capital Market under the ticker symbol "ETS" on August 21, 2025, with the offering expected to close on August 22, 2025, subject to customary closing conditions [2] Regulatory and Compliance Information - A registration statement on Form S-1 was filed with the U.S. Securities and Exchange Commission (SEC) and was declared effective on August 20, 2025 [3] - The offering is being made only by means of a prospectus forming part of the effective registration statement, with copies of the final prospectus to be available on the SEC's website [3]
X @Bloomberg
Bloomberg· 2025-08-20 00:30
Hong Kong's stock exchange is estimated to post a record profit for the second straight quarter, buoyed by an initial public offering and trading boom. https://t.co/resLgmszw9 ...
IPO & M&A Market Rebound: What it Means for Goldman's IB Business
ZACKS· 2025-08-19 17:36
Core Insights - Goldman Sachs is benefiting from the rebound in global deal-making activities, with its Global Banking & Markets division being the primary growth driver, accounting for 69.4% of total net revenues as of June 30, 2025 [1] Investment Banking Performance - In the first half of 2025, Goldman Sachs' investment banking fees increased by 8% year over year, with advisory revenues rising by 16%, debt underwriting revenues up by 2%, and equity underwriting revenues growing nearly 1% [2][11] - The firm maintains a leading position in announced and completed mergers and acquisitions (M&As), reinforcing its strength in the Global Banking & Markets sector [3] M&A and IPO Outlook - M&A activities are expected to remain strong in the second half of 2025, driven by higher stock valuations, pent-up demand, and corporate strategies for greater scale and competitiveness, supported by regulatory changes under the Trump administration [4] - The IPO market is also showing signs of vitality, particularly in technology and crypto-related offerings, with a solid IPO pipeline anticipated through the end of 2025 [5][6] Competitive Landscape - Morgan Stanley's investment banking business has seen a modest increase of 1% year over year, while JPMorgan's total investment banking fees grew by 9% in the first half of 2025, indicating a competitive environment [7][8] Stock Performance and Valuation - Goldman Sachs shares have increased by 27.7% year to date, outperforming the industry growth of 23.2% [9] - The Zacks Consensus Estimate for Goldman Sachs' earnings implies year-over-year increases of 12.6% and 14.9% for 2025 and 2026, respectively, with upward revisions in estimates over the past 30 days [14] - Goldman Sachs currently trades at a forward price-to-earnings (P/E) ratio of 14.64X, slightly above the industry average of 14.47X [17]
McKinley Acquisition Corp Announces Full Exercise of Over-Allotment Option in connection with its Initial Public Offering
Globenewswire· 2025-08-19 16:47
Group 1 - McKinley Acquisition Corporation closed its initial public offering of 15,000,000 units, with an additional 2,250,000 units issued due to the underwriter's over-allotment option, resulting in total gross proceeds of $172,250,000 priced at $10.00 per unit [1][3] - The units began trading on Nasdaq under the symbol "MKLYU" on August 13, 2025, with each unit consisting of one Class A ordinary share and one right, where each right entitles the holder to receive one-tenth of a Class A ordinary share upon the initial business combination [2] - A total of $172,500,000 from the offering proceeds was placed in trust, reflecting the amount raised from the public offering [3] Group 2 - Clear Street LLC served as the sole book-running manager for the offering, while Brookline Capital Markets acted as co-manager [4]
X @mert | helius.dev
mert | helius.dev· 2025-08-19 14:00
a company just IPO'd in the USA and received 1.15B $ in stablecoinsmostly on Solanagood chainBullish (@Bullish):Bullish has arranged to receive $1.15 billion of proceeds from its recently completed initial public offering in stablecoins, which represents a historic step for the use of stablecoins in an initial public offering in the United States.https://t.co/hh9i22RS9I ...
Urbana Corporation Announces the Recent Initial Public Offering of One of Its Investees
Globenewswire· 2025-08-18 16:52
Core Viewpoint - Urbana Corporation's investee company, Miami International Holdings Inc. (MIH), successfully completed an initial public offering (IPO) on the New York Stock Exchange (NYSE) [2][3] Group 1: IPO Details - MIH shares began trading on the NYSE on August 14, 2025, with an IPO price of US$23.00 per share [3] - The IPO raised a total of US$396,750,000 by issuing 15,000,000 shares, including an over-allotment option for an additional 2,250,000 shares [3] - MIH shares closed at US$31.12 on August 15, 2025, indicating a strong market performance post-IPO [3] Group 2: Urbana's Investment - Urbana owns 663,810 shares of MIAX, with an acquisition cost of CAD$12.3 million [4] - The market value of Urbana's MIAX shares was approximately CAD$28.5 million as of August 15, 2025, reflecting an unrealized gain of about CAD$16.2 million, or approximately 132% [4] Group 3: Company Background - Urbana Corporation is a diversified entity focusing on financial services, information services, and innovative technologies, aiming for income and capital appreciation through public and private investments [6] - Miami International Holdings, Inc. is a technology-driven leader in operating regulated financial markets across various asset classes, owning multiple exchanges including MIAX and the Bermuda Stock Exchange [7]
X @Decrypt
Decrypt· 2025-08-16 00:15
Company Announcement - Gemini, founded by Tyler and Cameron Winklevoss, has filed with the SEC to go public [1] Regulatory Filing - The crypto exchange Gemini has filed with the SEC [1]
Nasus Pharma Announces Closing of Initial Public Offering
Globenewswire· 2025-08-14 20:05
Core Viewpoint - Nasus Pharma Ltd. has successfully closed its initial public offering (IPO) of 1,250,000 ordinary shares at a price of $8.00 per share, raising gross proceeds of $10 million, which will be used to advance its intranasal Epinephrine program and for general corporate purposes [1][2]. Group 1: IPO Details - The IPO consisted of 1,250,000 ordinary shares priced at $8.00 each, resulting in gross proceeds of $10 million before expenses [1]. - Shares began trading on the NYSE American LLC under the ticker symbol "NSRX" on August 13, 2025 [1]. - Underwriters have an option to purchase an additional 187,500 shares within 45 days at the IPO price [1]. Group 2: Use of Proceeds - The net proceeds from the IPO will primarily fund the development of the intranasal Epinephrine program, including manufacturing scale-up and additional Phase 2 studies [2]. - Remaining funds will be allocated for general and administrative purposes, including working capital and capital expenditures [2]. Group 3: Company Overview - Nasus Pharma is a clinical-stage pharmaceutical company focused on developing intranasal powder products for acute medical conditions [5]. - The company's lead product candidate, NS002, is an intranasal powder formulation of Epinephrine designed as a needle-free alternative for anaphylaxis treatment [5]. - The proprietary powder-based intranasal (PBI) technology aims for rapid and reliable drug delivery, utilizing the nasal cavity's vascular network for quick absorption [5].
Miami International Holdings Announces Pricing of Initial Public Offering
Prnewswire· 2025-08-13 22:20
Company Overview - Miami International Holdings, Inc. (MIH) is a technology-driven leader in building and operating regulated financial markets across multiple asset classes [1][5] - MIH owns several exchanges including Miami International Securities Exchange (MIAX), MIAX PEARL, MIAX Emerald, MIAX Sapphire, MIAX Futures Exchange, MIAX Derivatives Exchange (MIAXdx), Dorman Trading, Bermuda Stock Exchange (BSX), and The International Stock Exchange (TISE) [5][6][8] Initial Public Offering (IPO) Details - MIH announced the pricing of its initial public offering of 15,000,000 shares at a price of $23.00 per share, which is $2.00 above the high end of the expected price range [1] - The shares are expected to begin trading on the New York Stock Exchange under the ticker symbol "MIAX" on August 14, 2025, with the offering expected to close around August 15, 2025 [1] - MIH has granted underwriters a 30-day option to purchase up to an additional 2,250,000 shares at the initial public offering price [1] Underwriters - J.P. Morgan, Morgan Stanley, and Piper Sandler are acting as lead joint bookrunning managers for the proposed offering [2] - Keefe, Bruyette & Woods, Inc., Raymond James, William Blair, and Rosenblatt are acting as joint bookrunning managers [2] Regulatory Information - A registration statement on Form S-1 relating to MIH's common stock was declared effective by the SEC on August 13, 2025 [4] - The offering of MIH's shares is being made only by means of a prospectus, which can be obtained for free from the SEC's website or through the underwriters [3]